Video summary

Tired All Day? It's Not Sleep, It's Your Mitochondria - Dr Trevor Bachmeyer

Main summary

Key takeaways

Wellness and Self-Improvement

Key message

If you’re sleeping enough but still feel exhausted, the speaker argues it’s usually not a sleep hygiene problem or a neurotransmitter/willpower problem. Instead, the core issue is primarily a mitochondrial/energy infrastructure problem—specifically poor ATP production—which then drives downstream problems in metabolism and immune regulation.

Core wellness / self-care strategies (as presented)

  • Stop masking fatigue and fix the system

    • Avoid treating symptoms while the underlying biology remains “broken.”
    • Don’t rely on sedatives/antihistamines (example: diphenhydramine/ZzzQuil), because the speaker claims they may worsen immune function and increase risk (including cancer risk and reduced natural killer cell activity).

  • Reframe fatigue as ATP / mitochondrial dysfunction

    • Fatigue is described as resulting from:
      • ATP “tanks” due to damaged mitochondrial electron transport chain (ETC)
      • Oxidative stress from electron leakage (reactive oxygen species / free radicals)
      • A “circle of death” where inflammation further damages mitochondria and reduces ATP even more

  • Use a “three biological failure” model (treat all three together)

    • Persistent fatigue is framed as three simultaneous failures:
      1. Energy production failure (ETC / ATP problem)
      2. Insulin resistance as a downstream symptom (not the root cause)
      3. Immune dysregulation / chronic inflammation driven by low ATP and impaired regulatory T-cells

  • Night = “repair window,” but only if the energy system can repair

    • Sleep is described as time allocated for repair—not the repair capability itself.
    • If mitochondrial repair capacity is impaired, sleep won’t fully restore you.

Intervention approach (three synergistic interventions)

The speaker proposes three combined interventions aimed at rebuilding mitochondrial function and reducing inflammation—especially around nighttime “repair” and daytime “performance.”

1) MOTS-c (mitochondrial-derived peptide)

  • Purpose: activate AMPK (“metabolic switch”) and shift from storage/anabolic toward repair/catabolic mode.
  • Effects described:
    • Moves GLUT4 transporters to the cell membrane → improves glucose entry
    • Suppresses mTOR → reduces fat-storage signaling
    • Triggers mitophagy (removal of damaged mitochondria)
    • Increases PGC-1α → supports mitochondrial biogenesis (new mitochondria)
  • Timing (as stated): don’t take it before bed (use during the day).

2) NAD+ (given as subcutaneous, “subQ” in the talk)

  • Purpose: support mitochondrial electron transfer (“electron shuttle”).
  • Effects described:
    • Restores ETC electron flow and reduces electron back-up/free radical leakage
    • Supports sirtuin activation during sleep (repair / quality-control signaling)
    • Promotes mitochondrial respiration capacity and repair processes
  • Timing / framing (as stated):
    • Use subQ; oral forms are dismissed by the speaker as being metabolized before reaching mitochondria
    • Positioned as a nighttime support (“when NAD+ is elevated during sleep…”)

3) Methylene blue

  • Purpose: provide a secondary electron pathway when the primary ETC is stressed.
  • Effects described:
    • Reduces reactive oxygen species
    • Helps suppress inflammatory signaling (emphasis on NF-κB)
    • Supports regulatory T-cell function by preserving ATP for immune regulation
    • Improves sleep quality (linked to reduced nighttime oxidative stress and better sleep)
  • Timing: the speaker says not before bed (discussed in the “night repair” context shortly after; the main caution is “don’t take it before you go to bed”).

Productivity / energy guidance embedded in the message

  • Aim for stable energy during the day rather than stimulants
    • Coffee is described as acceptable, but the goal isn’t “more stimulation”—it’s maintaining mitochondrial ATP function so you avoid the typical afternoon crash.

Research claims referenced (used to justify the strategy)

The speaker repeatedly cites studies/authors to support themes including:

  • Mitochondrial dysfunction correlating with fatigue severity
  • ATP production capacity predicting energy, cognition, and exercise tolerance
  • Mitochondrial dysfunction preceding insulin resistance
  • Regulatory T-cell function depending on mitochondrial oxidative phosphorylation
  • Synergy of combining NAD+ + MOTS-c + methylene blue to improve mitochondrial replacement and fatigue outcomes

Presenters / sources mentioned

  • Dr. Trevor Bachmeyer (presenter)
  • Selman Picard (fatigue + mitochondrial dysfunction study referenced; cited 2014)
  • Lopez-Lluch (mitochondrial biogenesis / NAD+ references; cited 2016/2018)
  • Yoshino (NAD+ decline/augmentation; cited 2016 and other work)
  • Fulco (NAD+-dependent sirtuin activation; cited “Cell” 2017)
  • Buck (regulatory T-cells / immune function and mitochondrial reliance; cited 2017)
  • Mills (Nature Immunology mechanism mapping; cited 2018)
  • Tricarico (systems biology causal pathway mapping; cited 2018)
  • Solis Herrera (mitochondrial dysfunction / insulin sensitivity; cited multiple years)
  • Callaway (methylene blue + sleep/oxidative stress; cited 2018)
  • Musharraf (NAD+ and exercise tolerance; cited in “gerontology”)
  • Lopez Luch (duplicate/variant name used by the speaker in multiple spots)
  • Yen (combined mitochondrial interventions increasing mitochondrial replacement rate; cited 2020)
  • Perinan (NAD+ and MOTS-c increasing overall ATP output; cited 2021)
  • Shondorf (ATP synthesis capacity in fatigue patients with combined NAD+ and methylene blue; cited 2019)
  • PLOS ONE – Lin (methylene blue restoring ATP and reducing ROS in ETC dysfunction; cited 2014)
  • Nature Metabolism (2021) (Perinan-related study citation)

Original video